Journal article

Development and validation of a simple tool for the assessment of home noninvasive ventilation: the S3-NIV questionnaire.

  • Dupuis-Lozeron E Division of Clinical Epidemiology, Geneva University Hospitals, Geneva, Switzerland.
  • Gex G Division of Lung Diseases, Hôpital du Valais, Sion, Switzerland.
  • Pasquina P Division of Lung Diseases, Geneva University Hospitals, Geneva, Switzerland.
  • Bridevaux PO Division of Lung Diseases, Hôpital du Valais, Sion, Switzerland.
  • Borel JC AGIR à dom, Grenoble, France.
  • Soccal PM Division of Lung Diseases, Geneva University Hospitals, Geneva, Switzerland.
  • Windisch W Cologne Merheim Hospital, Dept of Pneumology, Kliniken der Stadt Köln, Cologne, Germany.
  • Pépin JL HP2 Laboratory, Inserm U1042 Unit, Grenoble Alps University, Grenoble, France.
  • Janssens JP Division of Lung Diseases, Geneva University Hospitals, Geneva, Switzerland.
  • Adler D Division of Lung Diseases, Geneva University Hospitals, Geneva, Switzerland.
Show more…
  • 2018-09-29
Published in:
  • The European respiratory journal. - 2018
English Patient-centred outcomes are significantly modified by long-term home noninvasive ventilation (NIV), but a short, self-administered, specific tool for routine clinical assessment is lacking. The aim of this study was to develop and validate the S3-NIV questionnaire, a short questionnaire to measure respiratory symptoms, sleep quality and NIV-related side effects.Patients with stable disease who were under long-term home NIV were recruited from three outpatient NIV services. Questionnaire development consisted of a selection of core items for analysis, followed by item reduction, validation and test-retest reliability.338 patients completed a 22-item questionnaire. 11 items were removed because of non-scalability (n=2), redundancy (n=8) and lack of fit (n=1). The final version of the S3-NIV questionnaire consisted of 11 items covering two dimensions: "respiratory symptoms" (Cronbach's α=0.84) and "sleep & NIV-related side effects" (Cronbach's α=0.77). Convergent validity was high between the "respiratory symptoms" subscale of the S3-NIV questionnaire and the St George's Respiratory Questionnaire (rho= -0.76, p<0.001), and between the "sleep & NIV-related side effects" subscale and the Quebec Sleep Questionnaire (rho=0.51, p<0.001). The S3-NIV questionnaire had good test--retest reliability after 4 weeks (intraclass correlation coefficient=0.72).The S3-NIV questionnaire is a short, valid and repeatable self-completed tool for the routine clinical assessment of patients undergoing home NIV.
Language
  • English
Open access status
bronze
Identifiers
Persistent URL
https://sonar.ch/global/documents/138022
Statistics

Document views: 49 File downloads:
  • fulltext.pdf: 0